Page 1 of Clinical Trials for Surface Logix [SPONSOR-COLLABORATORS], 6 Total Matches
- 1CompletedSafety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With HypertensionLast Updated: December 17, 2008Condition(s): Hypertension
- 2CompletedLast Updated: December 14, 2009Condition(s): Type 2 Diabetes
- 3CompletedLast Updated: December 17, 2008Condition(s): Raynaud's Disease
- 4CompletedLast Updated: December 17, 2008Condition(s): Hypertension
- 5CompletedLast Updated: December 17, 2008Condition(s): Hypertriglyceridemia
- 6CompletedLast Updated: December 14, 2009Condition(s): Hyperlipidemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Surface+Logix
